Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyungjoo Cho

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|December 24, 2021
Pharmacological Inhibition of Sonic Hedgehog Signaling Suppresses Tumor Development in a Murine Model of Intrahepatic CholangiocarcinomaKyungjoo Cho, Hyuk Moon, Sang Hyun Seo, et al.
The Journal of Obstetrics and Gynaecology Research|November 19, 2016
Effect of number of retrieved lymph nodes on prognosis in FIGO stage IB-IIA cervical cancer patients treated with primary radical surgerySoyi Lim, Kyungjoo Cho, Seungho Lee, et al.
International Journal of Molecular Sciences|February 1, 2019
High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling PathwayHyuk Moon, Kyungjoo Cho, Sunyeong Shin, et al.
Cancers|December 22, 2019
Genetically Engineered Mouse Models for Liver CancerKyungjoo Cho, Simon Weonsang Ro, Sang Hyun Seo, et al.
Hepatology (Baltimore, Md.)|June 8, 2021
YAP/TAZ Suppress Drug Penetration Into Hepatocellular Carcinoma Through Stromal ActivationKyungjoo Cho, Simon Weonsang Ro, Hye Won Lee, et al.
Cancers|June 10, 2022
Anti-Cancer Effects of YAP Inhibitor (CA3) in Combination with Sorafenib against Hepatocellular Carcinoma (HCC) in Patient-Derived Multicellular Tumor Spheroid Models (MCTS)Sojung Han, Ji Yeon Lim, Kyungjoo Cho, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2017
Deubiquitinase YOD1 potentiates YAP/TAZ activities through enhancing ITCH stabilityYoungeun Kim, Wantae Kim, Yonghee Song, et al.
American Journal of Cancer Research|March 9, 2022
A micellized bone morphogenetic protein-7 prodrug ameliorates liver fibrosis by suppressing transforming growth factor-<i>β</i> signalingKyungjoo Cho, Nam Hee Kim, Sang Hyun Seo, et al.
Nature Communications|January 16, 2023
Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtypingHee Seung Lee, Dai Hoon Han, Kyungjoo Cho, et al.
Gut|January 21, 2021
Impaired antibacterial response of liver sinusoidal Vγ9<sup>+</sup>Vδ2<sup>+</sup> T cells in patients with chronic liver diseaseMin-Seok Rha, Ji Won Han, June-Young Koh, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|December 24, 2021
Pharmacological Inhibition of Sonic Hedgehog Signaling Suppresses Tumor Development in a Murine Model of Intrahepatic CholangiocarcinomaKyungjoo Cho, Hyuk Moon, Sang Hyun Seo, et al.
The Journal of Obstetrics and Gynaecology Research|November 19, 2016
Effect of number of retrieved lymph nodes on prognosis in FIGO stage IB-IIA cervical cancer patients treated with primary radical surgerySoyi Lim, Kyungjoo Cho, Seungho Lee, et al.
International Journal of Molecular Sciences|February 1, 2019
High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling PathwayHyuk Moon, Kyungjoo Cho, Sunyeong Shin, et al.
Cancers|December 22, 2019
Genetically Engineered Mouse Models for Liver CancerKyungjoo Cho, Simon Weonsang Ro, Sang Hyun Seo, et al.
Hepatology (Baltimore, Md.)|June 8, 2021
YAP/TAZ Suppress Drug Penetration Into Hepatocellular Carcinoma Through Stromal ActivationKyungjoo Cho, Simon Weonsang Ro, Hye Won Lee, et al.
Cancers|June 10, 2022
Anti-Cancer Effects of YAP Inhibitor (CA3) in Combination with Sorafenib against Hepatocellular Carcinoma (HCC) in Patient-Derived Multicellular Tumor Spheroid Models (MCTS)Sojung Han, Ji Yeon Lim, Kyungjoo Cho, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2017
Deubiquitinase YOD1 potentiates YAP/TAZ activities through enhancing ITCH stabilityYoungeun Kim, Wantae Kim, Yonghee Song, et al.
American Journal of Cancer Research|March 9, 2022
A micellized bone morphogenetic protein-7 prodrug ameliorates liver fibrosis by suppressing transforming growth factor-<i>β</i> signalingKyungjoo Cho, Nam Hee Kim, Sang Hyun Seo, et al.
Nature Communications|January 16, 2023
Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtypingHee Seung Lee, Dai Hoon Han, Kyungjoo Cho, et al.
Gut|January 21, 2021
Impaired antibacterial response of liver sinusoidal Vγ9<sup>+</sup>Vδ2<sup>+</sup> T cells in patients with chronic liver diseaseMin-Seok Rha, Ji Won Han, June-Young Koh, et al.
Pageof 1